Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 202

Results For "EMA"

2239 News Found

Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation
Hospitals | September 29, 2021

Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation

Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age


Fortis Hospital conducts complex surgery to save a patient with recurrent heart failure
Hospitals | September 29, 2021

Fortis Hospital conducts complex surgery to save a patient with recurrent heart failure

A team of experts at Fortis Gurugram conducted 3-dimensional mapping with the help of the new system Carto version 7 to precisely map the source of the arrhythmia. It was detected that the arrhythmia was coming from the conduction system i.e. body’s natural wiring.


Dr Reddy’s creates world’s largest toothbrush sculpture
Events | September 29, 2021

Dr Reddy’s creates world’s largest toothbrush sculpture

Fastminar is a 40-feet structure made with approximately 80,000 toothbrushes and is located at Terna Dental College in Navi Mumbai


Shalby Hospitals teams up with Ganpat university to offer MBA in healthcare management
Hospitals | September 29, 2021

Shalby Hospitals teams up with Ganpat university to offer MBA in healthcare management

The aspirant can enrol in MBA (Healthcare and Hospital Management) at Ganpat University, -Centre for Management Studies and Research, which will be facilitated by Ganpat University and Shalby Centre for Healthcare Management and Research


MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9
Drug Approval | September 29, 2021

MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9

India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys


Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer
Drug Approval | September 28, 2021

Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer

Prostate cancer is the second-most common cancer in men and despite an increase in the number of available treatments for men with mCRPC, five-year survival remains low


Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027
News | September 28, 2021

Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027

One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports


SpeeDx and SynGenis partner for custom oligonucleotide synthesis
Supply Chain | September 28, 2021

SpeeDx and SynGenis partner for custom oligonucleotide synthesis

The investment will increase SpeeDx internal capacity to scale up manufacturing


Bal Pharma ramps up API capacity of Gliclazide
News | September 28, 2021

Bal Pharma ramps up API capacity of Gliclazide

In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report


U.S. FDA approves Repatha for paediatric patients aged 10 years and older
Drug Approval | September 27, 2021

U.S. FDA approves Repatha for paediatric patients aged 10 years and older

The FDA also approved Repatha as an adjunct to other LDL-C lowering therapies for the treatment of homozygous familial hypercholesterolemia (HoFH) for younger pediatric patients